Verastem, Inc. (LON:0LOV)
London · Delayed Price · Currency is GBP · Price in USD 10.28
+0.24 (2.44%)
At close: Nov 26, 2025
Verastem Market Cap
Verastem has a market cap or net worth of 600.11 million as of November 26, 2025. Its market cap has increased by 341.20% in one year.
Market Cap
600.11M
Enterprise Value
563.52M
Revenue
9.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.28
Market Cap Chart
Since January 27, 2012, Verastem's market cap has increased from 142.97M to 600.11M, an increase of 319.73%. That is a compound annual growth rate of 10.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 600.11M | 226.51% |
| Dec 31, 2024 | 183.80M | 13.82% |
| Dec 29, 2023 | 161.48M | 130.08% |
| Dec 30, 2022 | 70.18M | -74.56% |
| Dec 31, 2021 | 275.82M | 4.14% |
| Dec 31, 2020 | 264.86M | 252.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.31B |
| GSK plc | 71.84B |
| Haleon | 33.60B |
| Smith & Nephew | 10.61B |
| ConvaTec Group | 4.65B |
| Hikma Pharmaceuticals | 3.53B |
| HUTCHMED (China) | 1.86B |
| Genus | 1.65B |